Discover
RNXT
RenovoRx, Inc.
0.88
1 x 0.82
1 x 0.98
bid
ask
+
0.00
0.00%
41 @ 04:00 PM
0.90 +0.02 (2.55%)
| Ytd | 4.46% | |
| 1y | -31.97% |
day range
0.70
52 week range
1.45
| Open | Prev Close | 0.88 | Low | High | Mkt Cap | 32.67M | |||
| Vol | 0.00 | Avg Vol | 266.54K | EPS | -0.32 | P/E | -2.74 | Forward P/E | -3.10 |
| Beta | 0.99 | Short Ratio | 3.43 | Inst. Own | 8.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.89 | 200-d Avg | 0.95 | 1yr Est | 5.50 |
| Income Statement | |||
| Total Revenue | 563.00K | ||
| Revenues (USD) | 563.00K | ||
| Cost of Revenue | 84.00K | ||
| Gross Profit | 479.00K | ||
| Operating Expenses | 3.95M | ||
| Research and Development Expense | 1.23M | ||
| Selling, General and Administrative Expense | 2.72M | ||
| Operating Income | -3.47M | ||
| Net Income | -3.52M | ||
| Net Income Common Stock | -3.52M | ||
| Net Income Common Stock (USD) | -3.52M | ||
| Consolidated Income | -3.52M | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -3.52M | ||
| Earning Before Interest & Taxes (USD) | -3.52M | ||
| Weighted Average Shares | 38.03M | ||
| Weighted Average Shares Diluted | 38.03M | ||
| Balance Sheet | |||
| Cash and Equivalents | 12.36M | ||
| Cash and Equivalents (USD) | 12.36M | ||
| Trade and Non-Trade Receivables | 280.00K | ||
| Current Assets | 13.72M | ||
| Property, Plant & Equipment Net | 244.00K | ||
| Total Assets | 13.96M | ||
| Total Debt | 78.00K | ||
| Current Liabilities | 1.92M | ||
| Debt Non-Current | 78.00K | ||
| Total Liabilities | 2.70M | ||
| Accumulated Retained Earnings (Deficit) | -64.91M | ||
| Shareholders Equity | 11.27M | ||
| Shareholders Equity (USD) | 11.27M | ||
| Assets Non-Current | 244.00K | ||
| Total Debt (USD) | 78.00K | ||
| Inventory | 379.00K | ||
| Liabilities Non-Current | 779.00K | ||
| Trade and Non-Trade Payables | 1.12M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 24.00K | ||
| Net Cash Flow from Financing | 9.05M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.34M | ||
| Issuance (Purchase) of Equity Shares | 9.05M | ||
| Net Cash Flow from Operations | -3.71M | ||
| Share Based Compensation | 317.00K | ||